INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 425m ago
HOUSE PTR24m ago
SEC 13F24m ago
ROBINHOOD CHAIN24m ago
Corporate insider
WE

Warren Eric

Chief Commercial OfficerCIK 0001916048

EDGAR filingsOpen in network
Disclosed transactions9
Buys / sells0 / 3
Max Insider Score41
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
0
WE
Warren EricChief Commercial Officer
MLYSMineralys Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
7,438 sh
Sep 21, 2026Sep 22, 2026
traded Sep 21, 2026
+1dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Mineralys Therapeutics, Inc.Chief Commercial Officer · Jun 30, 2026
13
WE
Warren EricChief Commercial Officer
MLYSMineralys Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL
$209K
7,438 sh
Sep 21, 2026
Sep 22, 2026
traded Sep 21, 2026
+1d
SEC FORM 4

Evidence

2
WE
Warren EricChief Commercial Officer
MLYSMineralys Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$98K
7,438 sh
Sep 21, 2026Sep 22, 2026
traded Sep 21, 2026
+1dSEC FORM 4

Evidence

0
WE
Warren EricChief Commercial Officer
MLYSMineralys Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
7,437 sh
Aug 21, 2026Aug 25, 2026
traded Aug 21, 2026
+4dSEC FORM 4

Evidence

2
WE
Warren EricChief Commercial Officer
MLYSMineralys Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$98K
7,437 sh
Aug 21, 2026Aug 25, 2026
traded Aug 21, 2026
+4dSEC FORM 4

Evidence

13
WE
Warren EricChief Commercial Officer
MLYSMineralys Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$193K
7,437 sh
Aug 21, 2026Aug 25, 2026
traded Aug 21, 2026
+4dSEC FORM 4

Evidence

20
WE
Warren EricChief Commercial Officer
MLYSMineralys Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$1.38M
104.1K sh
Jun 26, 2026Jun 30, 2026
traded Jun 26, 2026
+4dSEC FORM 4

Evidence

41
WE
Warren EricChief Commercial Officer
MLYSMineralys Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$2.70M
104.1K sh
Jun 26, 2026Jun 30, 2026
traded Jun 26, 2026
+4dSEC FORM 4

Evidence

11
WE
Warren EricChief Commercial Officer
MLYSMineralys Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
104.1K sh
Jun 26, 2026Jun 30, 2026
traded Jun 26, 2026
+4dSEC FORM 4

Evidence